Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hester Biosciences Limited ( (IN:HESTERBIO) ) has issued an update.
Hester Biosciences Limited has announced a change in its Key Managerial Personnel (KMP) authorization as per SEBI regulations. The Board of Directors has approved the appointment of Mr. Ashish Desai as the new Chief Financial Officer and KMP, which aligns with the company’s policy on materiality disclosure. This change is expected to enhance the company’s financial management and compliance with regulatory requirements, potentially impacting its operational efficiency and stakeholder confidence.
More about Hester Biosciences Limited
Hester Biosciences Limited operates in the biotechnology industry, focusing primarily on the production of animal vaccines and health products. The company is known for its innovative solutions in veterinary healthcare, serving a diverse market that includes livestock and poultry sectors.
Average Trading Volume: 487
Technical Sentiment Signal: Sell
Current Market Cap: 14.17B INR
See more insights into HESTERBIO stock on TipRanks’ Stock Analysis page.